Literature DB >> 4580022

Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial.

.   

Abstract

A study was designed to investigate the effect on morbidity and mortality of lowering diastolic blood pressure levels of between 100 and 120 mm Hg to below 100 mm Hg. Fifty-eight men and women, aged from 45-69 years, with blood pressure levels between 100 and 120 mm Hg were matched for age, sex, and blood pressure levels with 58 control patients. The maintenance of diastolic blood pressures at levels below 100 mm Hg was successfully carried out without serious drug side effects. Treatment effectively maintained diastolic pressures below 100 mm Hg, but no effect was shown on other terminating events. Few problems were found in the management of patients with minimally raised blood pressure, most of whom were symptom-free. The treatment and control groups became less comparable as increasing numbers of patients in the control group were withdrawn from the trial as diastolic pressures rose above 130 mm Hg.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4580022      PMCID: PMC1586420     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  A TRIAL OF LONG-TERM HYPOTENSIVE THERAPY IN CEREBROVASCULAR DISEASE.

Authors:  J MARSHALL
Journal:  Lancet       Date:  1964-01-04       Impact factor: 79.321

2.  THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION.

Authors:  M HAMILTON; E M THOMPSON; T K WISNIEWSKI
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

3.  HASTENING THE CONTROL OF BLOOD-PRESSURE BY GUANETHIDINE.

Authors:  A W LEISHMAN; G SANDLER
Journal:  Lancet       Date:  1965-03-27       Impact factor: 79.321

4.  Freedom from cerebral vascular accidents during drug-induced blood pressure reduction in "benign" hypertensive disease.

Authors:  R E LEE; A W SELIGMANN; M A CLARK; P A ROUSSEAU
Journal:  Am J Cardiol       Date:  1963-06       Impact factor: 2.778

5.  Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

Authors:  M HARINGTON; P KINCAID-SMITH; J McMICHAEL
Journal:  Br Med J       Date:  1959-11-14

6.  Semicontinuous screening of a whole community for hypertension.

Authors:  J T Hart
Journal:  Lancet       Date:  1970-08-01       Impact factor: 79.321

7.  Variation of blood-pressure in untreated hypertensive outpatients.

Authors:  J F Dunne
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

8.  A random-zero sphygmomanometer.

Authors:  B M Wright; C F Dore
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

9.  The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment.

Authors:  J R Caldwell; S Cobb; M D Dowling; D de Jongh
Journal:  J Chronic Dis       Date:  1970-02

10.  Effects of treatment in hypertension. Results of a controlled study.

Authors:  F W Wolff; R D Lindeman
Journal:  J Chronic Dis       Date:  1966-03
View more
  16 in total

1.  Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change.

Authors:  F Gueyffier; J Wright
Journal:  J Hum Hypertens       Date:  2013-08-29       Impact factor: 3.012

2.  Benefits of treatment of mild to moderate hypertension.

Authors:  C H Hennekens
Journal:  J Gen Intern Med       Date:  1987 Nov-Dec       Impact factor: 5.128

3.  The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.

Authors:  Tatiana V Macfarlane; Filippo Pigazzani; Robert W V Flynn; Thomas M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2018-11-28       Impact factor: 4.335

Review 4.  [Blood pressure and the brain].

Authors:  A Hartmann; S Moskau
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

Review 5.  Guidelines for the treatment of hypertension: a critical review.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 6.  Pharmacotherapy for hypertension in adults aged 18 to 59 years.

Authors:  Vijaya M Musini; Francois Gueyffier; Lorri Puil; Douglas M Salzwedel; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2017-08-16

Review 7.  Methyldopa for primary hypertension.

Authors:  Greg T Mah; Aaron M Tejani; Vijaya M Musini
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

8.  Comparative studies of guanfacine and methyldopa.

Authors:  A Roeckel; A Heidland
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

9.  Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death.

Authors:  Patricia R Hebert; Christopher S Coffey; Daniel W Byrne; Theresa A Scott; Robert H Fagard; Jeffrey N Rottman; Katherine T Murray; John A Oates
Journal:  J Am Soc Hypertens       Date:  2008 Sep-Oct

Review 10.  Risk and management of hypertension-related left ventricular hypertrophy.

Authors:  K K Teo
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.